Portfolio Monte Carlo Simulator mimics portfolio workflow from Ph1 to launch using decision trees to assess and analyze various risk mitigation strategies if the portfolio risk is high.
Projects/Programs in the portfolio could be interdependent. It means, for example, that if a lead indication fails in a clinical trial, then one of the non-lead indications becomes the lead indication. Also, If a drug fails in a clinical trial, the PTRS of drugs with the same mechanism of action will be reduced, and vice versa.
The Simulator also incorporates various risk mitigation options for each project/program in the portfolio. They include contingency planning, drug reformulation /repositioning, backups, secondary indications (growth strategies), and life cycle management strategies. Their incorporation will increase portfolio value.
The highest effect could be achieved if the Portfolio Optimizer and Portfolio Simulator are used jointly to derive portfolio planning solutions balanced across strategic goals, value, resources, and risk.
info@orbeeconsulting.com
Register now to get updates on promotions…
ORBee Consulting offers tools for strategic and operational planning in the biopharmaceutical industry, leveraging operations research techniques for optimization, simulation, statistical analysis, and analytical decision-making.
© Copyright MAVENUP 2024 All Right Reserved.
terms of use | privacy policy